These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26396518)

  • 1. Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome.
    Valencia M; Fresán A; Barak Y; Juárez F; Escamilla R; Saracco R
    Neuropsychiatr Dis Treat; 2015; 11():2339-48. PubMed ID: 26396518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
    El Gharbi I; Chhoumi M; Mechri A
    Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia.
    Valencia M; Fresan A; Juárez F; Escamilla R; Saracco R
    J Psychiatr Res; 2013 Dec; 47(12):1886-92. PubMed ID: 24112947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
    Schennach-Wolff R; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Huff W; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Möller HJ; Riedel M
    Schizophr Res; 2009 Sep; 113(2-3):210-7. PubMed ID: 19560901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia.
    Chang WC; Chan TC; Chen ES; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
    Schizophr Res; 2013 Jan; 143(1):107-15. PubMed ID: 23151398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
    Novick D; Haro JM; Suarez D; Lambert M; Lépine JP; Naber D
    Psychopharmacology (Berl); 2007 May; 191(4):1015-22. PubMed ID: 17310386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial functioning in relation to symptomatic remission: A longitudinal study of first episode schizophrenia.
    Jaracz K; Górna K; Kiejda J; Grabowska-Fudala B; Jaracz J; Suwalska A; Rybakowski JK
    Eur Psychiatry; 2015 Nov; 30(8):907-13. PubMed ID: 26647865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
    Hofer A; Bodner T; Kaufmann A; Kemmler G; Mattarei U; Pfaffenberger NM; Rettenbacher MA; Trebo E; Yalcin N; Fleischhacker WW
    Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia.
    Lambert M; Schimmelmann BG; Naber D; Schacht A; Karow A; Wagner T; Czekalla J
    J Clin Psychiatry; 2006 Nov; 67(11):1690-7. PubMed ID: 17196047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient population.
    Mosolov SN; Potapov AV; Ushakov UV
    Ann Gen Psychiatry; 2012 Jan; 11(1):1. PubMed ID: 22221826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment.
    Lambert M; De Marinis T; Pfeil J; Naber D; Schreiner A
    Eur Psychiatry; 2010 May; 25(4):220-9. PubMed ID: 19926263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic Remission in Schizophrenia and its Relationship with Functional Outcome Measures in Indian Population.
    Madhivanan S; Jayaraman K; Daniel SJ; Ramasamy J
    J Clin Diagn Res; 2017 Jan; 11(1):VC05-VC07. PubMed ID: 28274026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community.
    Bernardo M; Cañas F; Herrera B; García Dorado M
    Rev Psiquiatr Salud Ment; 2017; 10(3):149-159. PubMed ID: 27291833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly.
    Correll CU; Brieden A; Janetzky W
    Schizophrenia (Heidelb); 2023 Nov; 9(1):80. PubMed ID: 37935711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study.
    San L; Ciudad A; Alvarez E; Bobes J; Gilaberte I
    Eur Psychiatry; 2007 Nov; 22(8):490-8. PubMed ID: 17904337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia.
    Kokaçya MH; Virit O; Çöpoğlu ÜS; Savaş H; Ari M; Bahçeci B
    Noro Psikiyatr Ars; 2016 Dec; 53(4):328-333. PubMed ID: 28360807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.
    Novick D; Haro JM; Suarez D; Vieta E; Naber D
    Schizophr Res; 2009 Mar; 108(1-3):223-30. PubMed ID: 19070991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.
    Stahl SM; Malla A; Newcomer JW; Potkin SG; Weiden PJ; Harvey PD; Loebel A; Watsky E; Siu CO; Romano S
    J Clin Psychopharmacol; 2010 Aug; 30(4):425-30. PubMed ID: 20571437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders.
    Pinna F; Deriu L; Diana E; Perra V; Randaccio RP; Sanna L; Tusconi M; Carpiniello B;
    Ann Gen Psychiatry; 2015; 14():6. PubMed ID: 25699085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.